WANBURYNSEWanbury Limited· PharmaceuticalsLowNeutral
Announced Thu, 18 Sept · 17:51 IST

Wanbury Limited has informed the Exchange regarding Outcome of Committee Meeting held on September 18, 2025.

Board & Shareholder Meetings View source PDF

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Wanbury Limited has submitted to the NSE the outcome of a committee meeting that took place on September 18, 2025. The actual decisions, approvals, or matters discussed are not disclosed in this headline-level filing. Shareholders would need to refer to the detailed outcome filing or the company's filing on the NSE/BSE portal to understand the specific resolutions passed. Without further details, the nature of the committee (audit, risk, or other) and any financial implications remain unclear.

Likely market impact

No direct impact on shareholders or stock price can be determined from this announcement alone, as specific details of the committee meeting outcome are not included in the headline. Investors should review the full disclosure for any material information.